Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism. - Wikidata - awgldk - TriplyDB

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

http://www.wikidata.org/entity/Q34987988

about

Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells.Reduction of p53 by knockdown of the UGT1 locus in colon epithelial cells causes an increase in tumorigenesis.Pan-cancer analyses of the nuclear receptor superfamily Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11).Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer.Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response.Drug disposition in pathophysiological conditions.Indirect regulation of CYP2C19 gene expression via DNA methylation.Altered hepatic drug-metabolizing activity in rats suffering from hypoxemia with experimentally induced acute lung impairment.Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.Metabolic changes in the liver of mice with Ehrlich ascites carcinoma.Cancer-related inflammation: an emerging prognostic domain in metastatic castration-resistant prostate carcinoma.Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer

P2860

Q30434365-B512F8BE-E184-41CB-969C-174F82D18129 Q36487252-1C03762C-08EE-4304-9BD9-40B79DC6A0BA Q36907762-809A6AD9-84E4-40A4-8551-481208B21D41 Q37340600-5A3E04BC-66D0-48A7-8991-021CBE3E7052 Q37537548-803CC349-7BF5-4E74-AA42-A2B6876473C0 Q37964754-5C51E3EF-E380-414F-AA55-BB02129B2FF0 Q38022659-D7D387C7-BE2F-4D43-995E-9EFC5C0FDB0F Q38608601-11B0648A-6EF7-48BF-9023-A0161B3E0B33 Q50915138-1D5EBFC1-6041-4625-B7F8-9CF5DCBAA05B Q51055057-5FDE2AC7-19A8-4FCB-867D-8F86A66D08E8 Q53008969-891E2393-1F35-4E59-9905-D61B066A6786 Q53036820-6A8DE39E-6962-4710-99F4-864F1C69028D Q57245241-DEBB9EF3-B818-46A0-AEEE-3E78286077A7 Q58694195-B8BD4F20-68E1-434E-ABB1-8DBEDBCD1076

P2860

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

http://www.wikidata.org/entity/Q34987988

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

@ast

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

@en

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

@nl

type

label

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

@ast

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

@en

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

@nl

prefLabel

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

@ast

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

@en

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

@nl

P1433

Q34987988-C2C41F03-3DDF-447A-B3F1-CA6A247310EC

P1476

Q34987988-8432B7A4-D4A5-489D-9FC0-F86B4C49DFF5

P2093

Q34987988-1F23A908-2208-4452-8DB1-9924B32F9247

Q34987988-4ECF0E6B-9E32-4611-9DBF-0E643AB8CCAD

Q34987988-53313966-F5EB-4C34-A47A-A7E473425F2A

Q34987988-C1F6C181-68A3-4508-AD3B-818DBABA1A68

Q34987988-D0878040-4C53-40E4-9E05-B93EF43E071D

Q34987988-EA8DDB1D-D3AF-4BA9-80D3-18A5DCA220F9

P2860

Q34987988-093FC6C3-010C-4321-A36A-F5A789AEC6F2

Q34987988-0A43DA07-B86F-48EE-BFFF-0AE71AEE380C

Q34987988-0BBA60BB-7296-491C-B159-802D940349DC

Q34987988-0C779142-0E66-434C-AF3B-D543F62BDEA0

Q34987988-0EB78487-F5D6-4E49-8ADD-5D6490C0961D

Q34987988-158FD659-F9AB-4D70-BFEE-486E2C208AD0

Q34987988-1CB9F368-493D-4D16-AF17-413C496A27F3

Q34987988-205CB195-AFC6-4AD4-91CF-4F732D21373B

Q34987988-2247A33B-775A-4D07-98F9-4627342DF662

Q34987988-229E24F9-BC28-42BF-BFB2-70C779CA4C74

P304

Q34987988-E607BFF8-AD2A-4202-9801-A1173CF83C1E

P31

Q34987988-61A5B799-243B-4B80-A2E2-BB235EA41A49

P356

Q34987988-636C6793-675B-4206-BE4F-3DE9034494DA

P407

Q34987988-19F96971-A16B-4A46-9B64-D44FDDB8D6D2

P433

Q34987988-9BC81180-1D76-4636-9DB5-2D5BDA607902

P478

Q34987988-AAC4FE7B-CAE6-4E92-BD3C-F2CB68D7934D

P50

Q34987988-4A5A3448-EB04-4F7D-B3CD-24B04900ADC6

P577

Q34987988-315B6B43-8C0B-4681-ADA6-203119AF75E2

P5875

Q34987988-ADA1D3F6-B288-4984-9FC1-23E6A5374054

P698

Q34987988-5CD48905-A348-4CB3-8917-6BAECD82815E

P932

Q34987988-E5833B15-D52C-4C5D-840D-180EB5826844

P356

1078-0432.CCR-10-3289

P1433

Clinical Cancer Research

P1476

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

@en

P2093

Christopher Liddle

http://www.w3.org/2001/XMLSchema#string

Graham R Robertson

http://www.w3.org/2001/XMLSchema#string

Marina Kacevska

http://www.w3.org/2001/XMLSchema#string

Michael R Downes

http://www.w3.org/2001/XMLSchema#string

Rohini Sharma

http://www.w3.org/2001/XMLSchema#string

Stephen J Clarke

http://www.w3.org/2001/XMLSchema#string

P2860

Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation

Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae

Retinoic acid-gated sequence-specific translational control by RARalpha

Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response.

Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.

Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock.

Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations

P304

3170-3180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-3289

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Ronald M. Evans

P577

2011-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51056284

http://www.w3.org/2001/XMLSchema#string

P698

21498392

http://www.w3.org/2001/XMLSchema#string

P932

3096719

http://www.w3.org/2001/XMLSchema#string